Beamion 44: A Study to Test How Well Zongertinib is Tolerated by People With Advanced Non-small Cell Lung Cancer With HER2 Mutations When Given in Combination With Chemotherapy With or Without Pembrolizumab
Clinical trial NCT07486817 · RECRUITING
Trial details
- NCT number
- NCT07486817
- Sponsor
- Boehringer Ingelheim
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-04
- Primary completion
- 2027-08-12
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.